Literature DB >> 528086

Preoperative normovolaemic haemodilution with dextran 70 as a thromboembolic prophylaxis in total in hip replacement.

S A Nillius, A Ahlberg, M Arborelius, B Rosberg.   

Abstract

The effect of preoperative normovolaemic haemodilution with dextran 70 in 57 patients undergoing total hip replacement for osteoarthritis, was evaluated with respect to the production of thrombosis and pulmonary embolism. The patients were randomly allocated to one group undergoing preoperative haemodilution and one control group receiving 500 ml dextran 70 during operation and again on the second postoperative day. Before operation blood was replaced by dextran 70 to lower the hematocrit to between 25 and 30. The blood drained from the patients was used to replace blood lost at operation. Between 10 and 14 days after operation the patients were examined by perfusion lung scan, chest radiography and bilateral phlebography. Twelve patients also had 133Xe ventilation scans. The incidence of deep vein thrombosis in the two groups did not differ significantly. Pulmonary embolism was significantly decreased in the preoperative haemodilution group. One patient in the control group had clinical symptoms of, and died from, pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528086     DOI: 10.1007/BF00265712

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  30 in total

1.  Hemodilution.

Authors:  K Messmer
Journal:  Surg Clin North Am       Date:  1975-06       Impact factor: 2.741

2.  Dextran and the prevention of postoperative thromboembolic complications.

Authors:  U F Gruber
Journal:  Surg Clin North Am       Date:  1975-06       Impact factor: 2.741

3.  Venous thrombosis after total hip replacement. Combined monitoring as a guide for prophylaxis and treatment.

Authors:  M Hume; R H Turner; T X Kuriakose; J Surprenant
Journal:  J Bone Joint Surg Am       Date:  1976-10       Impact factor: 5.284

4.  The scintigraphic definition of pulmonary embolism.

Authors:  B J McNeil; B L Holman; S J Adelstein
Journal:  JAMA       Date:  1974-02-18       Impact factor: 56.272

5.  Ventilation-perfusion lung scanning for pulmonary emboli.

Authors:  O Williams; J Lyall; M Vernon; D N Croft
Journal:  Br Med J       Date:  1974-03-30

6.  Pulmonary embolism--a clinical and autopsy study.

Authors:  I M Macintyre; C V Ruckley
Journal:  Scott Med J       Date:  1974-01       Impact factor: 0.729

7.  The complementary roles of chest radiography, lung scanning, and selective pulmonary angiography in the diagnosis of pulmonary embolism.

Authors:  D C Moses; T M Silver; J J Bookstein
Journal:  Circulation       Date:  1974-01       Impact factor: 29.690

8.  Prevention of thromboembolic disease after elective surgery of the hip.

Authors:  C M Evarts; E J Feil
Journal:  J Bone Joint Surg Am       Date:  1971-10       Impact factor: 5.284

9.  Prospective analysis of pulmonary embolism in the postoperative patient.

Authors:  R J Allgood; J H Cook; R J Weedn; H K Speed; W H Whitcomb; L J Greenfield
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

10.  Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.

Authors:  A Kline; L E Hughes; H Campbell; A Williams; J Zlosnick; K G Leach
Journal:  Br Med J       Date:  1975-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.